National Guideline Clearinghouse | Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120).

full-text ►

National Guideline Clearinghouse | Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120).



National Institute for Health and Care Excellence (NICE)

Guideline Title

Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120).

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Implantable cardioverter defibrillators and cardiac resynchronization therapy for arrhythmias and heart failure (review of TA95 and TA120). London (UK): National Institute for Health and Care Excellence (NICE); 2014 Jun. 71 p. (Technology appraisal guidance; no. 314).

Guideline Status

This is the current release of the guideline.

This guideline updates previous versions: National Institute for Health and Clinical Excellence (NICE). Cardiac resynchronisation therapy for the treatment of heart failure. London (UK): National Institute for Health and Clinical Excellence (NICE); 2007 May. 28 p. (Technology appraisal guidance; no. 120).

National Institute for Health and Clinical Excellence (NICE). Implantable cardioverter defibrillators for arrhythmias. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Jan 1. 33 p. (Technology Appraisal; no. 95).

This guideline meets NGC's 2013 (revised) inclusion criteria.